Spotlight on Clinical Trials
More than 200 clinical trials were presented at the AACR Annual Meeting 2025, including 24 phase III studies. The titles and text of the clinical trial abstracts are available on the online itinerary planner. Detailed summaries of these sessions can be found in AACR Annual Meeting News.
Clinical Trial Abstract Sessions
- Clinical Trial Abstract Plenary Sessions
- Clinical Trial Abstract Minisymposia
- Clinical Trial Abstract Poster Sessions
ONLINE PUBLICATION OF ABSTRACTS AND POSTERS
The full text of the Clinical Trial Abstracts were posted to the AACR Online Itinerary Planner and the Meeting App on April 25, 2025, except those abstracts that were selected for inclusion in the official AACR press program. Abstracts featured in the official AACR press program were made publicly available at the date and time of presentation, either at the meeting or an official AACR press conference.
Presenters of Clinical Trial Abstracts that were assigned to poster sessions were required to submit an e-poster. Clinical Trial e-posters are available to Annual Meeting registrants through October 31.
Four experts presented compelling studies, including results from the phase III KEYNOTE-689 trial.
Four promising studies showcased targeted therapies across several solid tumor types.
Presenters showcased four targeted therapies for non-small cell lung cancer being tested in the clinic.
The final Clinical Trials Plenary Session highlighted cutting-edge immunotherapies.